MIGHT TREATMENT OF HYPERCHOLESTEROLEMIA INCREASE NONCARDIAC MORTALITY

被引：143

作者：

OLIVER, MF

机构：

[1] Wynn Institute for Metabolic Research, London, NW89SQ

来源：

LANCET | 1991年 / 337卷 / 8756期

关键词：

D O I：

10.1016/0140-6736(91)93208-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1529 / 1531

页数：3

共 23 条

[1] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].

CANNER, PL ;

BERGE, KG ;

WENGER, NK ;

STAMLER, J ;

FRIEDMAN, L ;

PRINEAS, RJ ;

FRIEDEWALD, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255

[2]

CARLSON LA, 1988, ACTA MED SCAND, V223, P405

[3] SUPPRESSION OF LYMPHOID-CELL FUNCTION-INVITRO BY INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE BY LOVASTATIN [J].

CUTTS, JL ;

BANKHURST, AD .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989, 11 (08) :863-869

[4]

DAYTON S, 1969, CIRCULATION S2, V39, P1

[5]

EDERER F, 1971, LANCET, V2, P203

[6] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[7]

HEADY JA, 1980, LANCET, V2, P379

[8]

HJERMANN I, 1990, ATHER REV, V21, P103

[9]

HJERMANN I, 1981, LANCET, V2, P1303

[10] PREVENTION OF CORONARY-ARTERY DISEASE - A MEDICAL IMPERATIVE [J].

LEAF, A ;

RYAN, TJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) :1416-1419

← 1 2 3 →